BlackRock Fund Advisors’s Allergan plc AGN Stock Holding History

BlackRock Fund Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.1B	Buy	5,238,748 +35,339	+0.7%	+$7.32M	0.2%	73
2016 Q3	$1.2B	Buy	5,203,409 +64,678	+1%	+$15.8M	0.25%	59
2016 Q2	$1.19B	Buy	5,138,731 +69,225	+1%	+$16M	0.26%	56
2016 Q1	$1.36B	Sell	5,069,506 -74,478	-1%	-$21.3M	0.31%	47
2015 Q4	$1.61B	Buy	5,143,984 +268,590	+6%	+$80M	0.37%	40
2015 Q3	$1.33B	Buy	4,875,394 +6,214	+0.1%	+$1.91M	0.34%	42
2015 Q2	$1.48B	Buy	4,869,180 +133,688	+3%	+$39.9M	0.35%	41
2015 Q1	$1.41B	Buy	4,735,492 +1,686,054	+55%	+$481M	0.34%	46
2014 Q4	$785M	Buy	3,049,438 +141,256	+5%	+$35.3M	0.19%	73
2014 Q3	$702M	Buy	2,908,182 +742,446	+34%	+$166M	0.2%	67
2014 Q2	$483M	Sell	2,165,736 -380,829	-15%	-$78.9M	0.14%	126
2014 Q1	$524M	Buy	2,546,565 +76,905	+3%	+$15.2M	0.16%	96
2013 Q4	$415M	Buy	2,469,660 +454,965	+23%	+$71.1M	0.13%	121
2013 Q3	$290M	Buy	2,014,695 +267,705	+15%	+$35.7M	0.1%	178
2013 Q2	$221M	Buy	+1,746,990	New	+$198M	0.08%	249

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock Fund Advisors's AGN Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Allergan plc (AGN) stake by 0.68% in Q4 2016, buying an estimated $7.32M and bringing the position to 5,238,748 shares worth $1.1B. The position accounts for 0.2% of the portfolio, ranked #73.

BlackRock Fund Advisors first reported a position in AGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.61B in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

BlackRock Fund Advisors held 5,238,748 shares of Allergan plc worth $1.1B as of Q4 2016.
BlackRock Fund Advisors bought 35,339 Allergan plc shares in Q4 2016, an estimated $7.32M.
Allergan plc made up 0.2% of BlackRock Fund Advisors's portfolio in Q4 2016, its #73 holding.
BlackRock Fund Advisors first reported a position in Allergan plc in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Allergan plc position peaked at $1.61B in Q4 2015.
1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.